Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Impact of Serial Serum Free Light Chain Measurements on Response and Progression Assessments in Multiple Myeloma Patients with Measurable Disease

Blood (2024) 144 (Supplement 1): 1955.

https://doi.org/10.1182/blood-2024-208790

Published: 2024

Journal Articles

Monoclonal Gammopathy of Renal Significance: Diagnosis, Treatment and Prognosis. Experience in a Spanish Hospital Institution

Amalia Domingo-González, Lucía Pavía Pascual, Raúl Fernández-Prado, Jorge Jean Sandoval-Perez, Deborah Duarte-Balbuena, Alberto Velasco, Marina Menéndez Cuevas, Elena Prieto Pareja, Daniel Naya, Rafael Martos, Pablo Cannata-Ortiz, Elham Askari

Blood (2024) 144 (Supplement 1): 6883.

https://doi.org/10.1182/blood-2024-205445

Published: 2024

Journal Articles

The Role of Comprehensive Geriatric Assessment in Newly Diagnosed Multiple Myeloma Elderly Patients: Analysis of Single Spanish Institution

Elham Askari, Amalia Domingo-González, Elena Prieto Pareja, Rocio Nieves Salgado Sanchez, Berta Garcia Corral, Marta Hernandez Segurado, Eva Castillo Bazán, Celia Urrutia Rodriguez, Miriam Riesco, Ana Isabel Isabel Hormigo-Sánchez, Raul Cordoba

Blood (2024) 144 (Supplement 1): 6996.

https://doi.org/10.1182/blood-2024-208155

Published: 2024

Journal Articles

Real-Life Experience of the Combination of Daratumumab, Bortezomib, Melphalan, and Prednisone (DVMP) in Patients with Newly Diagnosed Multiple Myeloma Ineligible for Autologous Stem-Cell Transplantation

Amalia Domingo-González, Rafael Alonso Fernández, Ana Jiménez, Teresa De Soto Alvarez, Ana Lerma, Virginia Pradillo Fernandez, Gonzalo Benzo Callejo, Jose Sanchez-Pina, Elena Landete, Alberto Velasco, Marina Menéndez Cuevas, Mónica María López Riñón, Andrés Ramírez López, Alberto Lopez Garcia, María-Jesús Blanchard, Elham Askari

Blood (2023) 142 (Supplement 1): 4745.

https://doi.org/10.1182/blood-2023-186954

Published: 2023

Journal Articles

Clinical Characteristics, Treatment Approach and Long-Term Outcomes of 678 Patients with Symptomatic Waldenstrom's Macroglobulinemia: Comprehensive Insights from a Spanish Registry of IgM Gammapathies

Blood (2023) 142 (Supplement 1): 4406.

https://doi.org/10.1182/blood-2023-189581

Published: 2023

Journal Articles

Comprehensive Geriatric Assessment and Geriatric Intervention in Older Patients with Newly Diagnosed Lymphoma: A Prospective Study

Alberto Lopez Garcia, Ana Isabel Hormigo, Ignacio Mahillo, Elham Askari, Daniel Morillo, Maria Angeles Perez Saez, Elena Prieto, Miriam Riesco, Celia Urrutia, Francisco Javier Martinez Peromingo, Juan Ignacio Gonzalez Montalvo, Raul Cordoba

Blood (2023) 142 (Supplement 1): 5146.

https://doi.org/10.1182/blood-2023-181652

Published: 2023

Journal Articles

Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Included in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort

Blood (2022) 140 (Supplement 1): 4315–4317.

https://doi.org/10.1182/blood-2022-158538

Published: 2022

Journal Articles

Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody: Patient-Reported Outcomes from MonumenTAL-1

Blood (2022) 140 (Supplement 1): 4447–4449.

https://doi.org/10.1182/blood-2022-162555

Published: 2022

Journal Articles

Machine Learning Model Defines Higher Risk of Venous Thromboembolism in Young Adults with Multiple Myeloma

Inés Martínez-Alfonzo, Diego Velasco, Pablo Mínguez Paniagua, Ignacio Mahillo-Fernández, Elham Askari, Rosa Vidal Laso, Cristina Fernández Maqueda, Alberto Velasco, Ana González-Teomiro, Maria Civeira-Marín, Elena Prieto-Pareja, Sara Martín-Herrero, José Manuel Calvo Villas, Isabel Krsnik, Joaquín Sánchez-Garcia, Miguel Angel Alvarez, María Pilar Llamas Sillero, Juana Serrano-López

Blood (2022) 140 (Supplement 1): 2811–2812.

https://doi.org/10.1182/blood-2022-167058

Published: 2022

Journal Articles

Clonal Architecture and Evolution of Waldenström's Macroglobulinemia at the Single Cell Level

Cristina Jiménez, María García-Álvarez, Miguel Alcoceba, Alejandro Medina, Elham Askari, Veronica Gonzalez-Calle, Maria Casanova, Fernando Escalante Barrigón, M Eugenia Sarasquete, Marcos González Díaz, María Carmen Chillón Santos, Ramón García-Sanz

Blood (2022) 140 (Supplement 1): 3510–3511.

https://doi.org/10.1182/blood-2022-163057

Published: 2022

Journal Articles

Progression Risk and Long-Term Survival Trends of 915 Patients with Asymptomatic IgM Monoclonal Gammopathy

David F. Moreno, Cristina Jiménez, Fernando Escalante Barrigón, Elham Askari, Mario Arnao, Ángela Heredia, Magdalena Alcalá, Arancha Bermúdez, Ana Saus Carreres, Maria Casanova, Luis Palomera, Cristina Motllo, Ricarda Belen Garcia Sanchez, Ramón García-Sanz, Carlos Fernández De Larrea

Blood (2022) 140 (Supplement 1): 259–260.

https://doi.org/10.1182/blood-2022-163008

Published: 2022

Journal Articles

Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 Results from MonumenTAL-1

Blood (2022) 140 (Supplement 1): 384–387.

https://doi.org/10.1182/blood-2022-159707

Published: 2022

Journal Articles

Phase 1b Results for Subcutaneous Talquetamab Plus Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma

Blood (2021) 138 (Supplement 1): 161.

https://doi.org/10.1182/blood-2021-148813

Published: 2021

Journal Articles

Subcutaneous Teclistamab in Combination with Daratumumab for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma: Results from a Phase 1b Multicohort Study

Blood (2021) 138 (Supplement 1): 1647.

https://doi.org/10.1182/blood-2021-148723

Published: 2021

Journal Articles

Compassionate Use of Belantamab Mafodotin for Treatment of Patients with Relapsed/Refractory Multiple Myeloma Heavily Treated. Spanish Experience

Blood (2021) 138 (Supplement 1): 3775.

https://doi.org/10.1182/blood-2021-151267

Published: 2021

Journal Articles

Updated Phase 1 Results from MonumenTAL-1: First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

Amrita Y. Krishnan, Monique C. Minnema, Jesús G. Berdeja, Albert Oriol, Niels W.C.J. van de Donk, Paula Rodriguez-Otero, Elham Askari, Maria-Victoria Mateos, Luciano J. Costa, Raluca I. Verona, Xuewen Ma, Suzette Girgis, Shiyi Yang, Brandi W. Hilder, Jeffery Russell, Jenna D. Goldberg, Ajai Chari

Blood (2021) 138 (Supplement 1): 158.

https://doi.org/10.1182/blood-2021-146868

Published: 2021

Journal Articles

A Phase 1, First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) x CD3 Bispecific Antibody, in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Ajai Chari, MD, Jesus G. Berdeja, MD, Albert Oriol, Niels W. C. J. van de Donk, MD, Paula Rodriguez, Elham Askari, Maria-Victoria Mateos, MD PhD, Monique C. Minnema, MD PhD, Raluca Verona, PhD, Suzette Girgis, PhD BPharm, MS, Thomas Prior, Brandi W. Hilder, PhD, Jeffery Russell, MD PhD, Jenna D. Goldberg, MD, Amrita Krishnan, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-133873

Published: 2020

Journal Articles

The Brief Gah Scale (Geriatric Assessment in Hematology) Correlates Well with a Comprehensive Geriatric Assessment in Patients with Hematologic Malignancies

Raul Cordoba, MD PhD, Ana-Isabel Hormigo, MD, Javier Martinez-Peromingo, MD, Maria Jarana, RN, Marta Perez-Albacete, RN, Teresa Villaescusa, MD PhD, Elham Askari, MD, Jose Luiz Lopez Lorenzo, MD, Maria Angeles Perez-Saenz, MD PhD, Elena Prieto, MD, Maria Pilar Llamas Sillero, MD PhD

Blood (2018) 132 (Supplement 1): 4753.

https://doi.org/10.1182/blood-2018-99-116950

Published: 2018

Journal Articles

Analysis of Primary Hemostasis Alterations Induced By Ibrutinib Assessed By Shutter Speed and Aggregometry Impedance

Raul Cordoba, MD PhD, Rosa Vidal, MD, Aranzazu Garcia-Raso, PhD, Tamara Castaño, MD, Carlos Plaza, MD, Elham Askari, MD, Maria-Angeles Perez, MD PhD, Valentin Garcia Gutierrez, MD PhD, Pilar Llamas, MD PhD

Blood (2016) 128 (22): 4931.

https://doi.org/10.1182/blood.V128.22.4931.4931

Published: 2016

Journal Articles

Immunophenotype in Chronic Myelomonocytic Leukemia: Is It Closer to Myelodysplastic Syndromes or to Myeloproliferative Disorders?.

Dolores Subira, MD, PhD, Patricia Font, MD, Lucia Villalon, MD, Elena Gongora, MD, Cristina Serrano, MD, Mario Rodriguez-Paíno, MD, Elham Askari, MD, Susana Castañon, Tch, Raquel Gonzalo, Tch, Alejandro Roman, MD, Pilar LLamas, MD PhD, Ana Villegas, MD Phd

Blood (2007) 110 (11): 4621.

https://doi.org/10.1182/blood.V110.11.4621.4621

Published: 2007

NARROW

Impact of Serial Serum Free Light Chain Measurements on Response and Progression Assessments in Multiple Myeloma Patients with Measurable Disease

Monoclonal Gammopathy of Renal Significance: Diagnosis, Treatment and Prognosis. Experience in a Spanish Hospital Institution

The Role of Comprehensive Geriatric Assessment in Newly Diagnosed Multiple Myeloma Elderly Patients: Analysis of Single Spanish Institution

Real-Life Experience of the Combination of Daratumumab, Bortezomib, Melphalan, and Prednisone (DVMP) in Patients with Newly Diagnosed Multiple Myeloma Ineligible for Autologous Stem-Cell Transplantation

Clinical Characteristics, Treatment Approach and Long-Term Outcomes of 678 Patients with Symptomatic Waldenstrom's Macroglobulinemia: Comprehensive Insights from a Spanish Registry of IgM Gammapathies

Comprehensive Geriatric Assessment and Geriatric Intervention in Older Patients with Newly Diagnosed Lymphoma: A Prospective Study

Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Included in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort

Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody: Patient-Reported Outcomes from MonumenTAL-1

Machine Learning Model Defines Higher Risk of Venous Thromboembolism in Young Adults with Multiple Myeloma

Clonal Architecture and Evolution of Waldenström's Macroglobulinemia at the Single Cell Level

Progression Risk and Long-Term Survival Trends of 915 Patients with Asymptomatic IgM Monoclonal Gammopathy

Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 Results from MonumenTAL-1

Phase 1b Results for Subcutaneous Talquetamab Plus Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma

Subcutaneous Teclistamab in Combination with Daratumumab for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma: Results from a Phase 1b Multicohort Study

Compassionate Use of Belantamab Mafodotin for Treatment of Patients with Relapsed/Refractory Multiple Myeloma Heavily Treated. Spanish Experience

Updated Phase 1 Results from MonumenTAL-1: First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

A Phase 1, First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) x CD3 Bispecific Antibody, in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

The Brief Gah Scale (Geriatric Assessment in Hematology) Correlates Well with a Comprehensive Geriatric Assessment in Patients with Hematologic Malignancies

Analysis of Primary Hemostasis Alterations Induced By Ibrutinib Assessed By Shutter Speed and Aggregometry Impedance

Immunophenotype in Chronic Myelomonocytic Leukemia: Is It Closer to Myelodysplastic Syndromes or to Myeloproliferative Disorders?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only